Prestige Consumer Healthcare

Prestige Consumer Healthcare

Pharmaceuticals
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

$2.4B

Market Cap • 11/20/2026

1996

(30 years)

Founded

2005

(21 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,2

P/S

2

P/EBITDA

7,2

P/OCF

10,2

P/FCF

11

P/E

15,3

BVPS

41

EPS

3,2

Market Cap

Market Cap

2,4B

EV

4,4B

EV/Revenue

3,8

EV/EBITDA

13,5

EV/EBIT

15,2

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

2,1%

Total Yield

2,1%

Payout

0%

Retained Earnings

1,8B

Profitability

Gross Margin

52,5%

EBITDA Margin

28,1%

EBIT Margin

25%

Net Margin

13,3%

D&A/EBITDA

7,6%

R&D/Revenue

0%

Capex/Revenue

1,3%

Capex/D&A

42,5%

Capex/OCF

6,8%

SBC/OCF

4,6%

% PPE

3,4%

% Goodwill

14,9%

ROE

8,2%

ROIC

5,1%

Growth

CAGR Revenue 5Y

2,7%

CAGR Op. Income 5Y

-1,5%

CAGR Net Income 5Y

-2,9%

CAGR EPS 5Y

-1,8%

CAGR OCF 5Y

-0,8%

Leverage

N.D./EBITDA

6,3

Debt/Equity

0%

Current Ratio

2,9

Quick Ratio

1,7

Interest Coverage

440,8%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium